-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Developing the Future of CAR-T Cell Therapy Today

Sponsor: Novartis Pharmaceuticals
Program: Product Theaters
Sunday, December 6, 2020: 11:00 AM-12:00 PM

Amir Hefni, PhD

Novartis, London, ENG, GBR

Carolin Barth, MD

Novartis, Basel, CHE

See more of: Product Theaters